Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Federico Argüelles"'
Autor:
Pilar Navajas Hernández, Samer Mouhtar el Halabi, Ana Caridad González Parra, Teresa Valdés Delgado, Belén Maldonado Pérez, Luisa Castro Laria, Cloé Charpentier, Federico Argüelles-Arias
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The success of anti-tumor necrosis factor (TNF) drug strategies in the treatment of inflammatory bowel disease (IBD) is altered by the development of anti-drug antibodies that reduce their efficacy. Studies have shown that the HLA-DQA1⋆
Externí odkaz:
https://doaj.org/article/6a3ecb5cb88c43c9ab2fdebd178284e0
Autor:
Jaime González-Antuña, Teresa Valdés-Delgado, Belén Maldonado-Pérez, María Belvis-Jiménez, Luisa Castro-Laria, Vicente Merino-Bohórquez, Miguel Ángel Calleja-Hernández, Paula Castro-Martínez, Cloe Charpentier, Federico Argüelles-Arias
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Ustekinumab (UST) is an effective treatment option in Crohn’s disease (CD) and ulcerative colitis (UC). However, it still remains unclear if therapeutic drug monitoring could be helpful to guide clinicians. Objectives: The aim of our st
Externí odkaz:
https://doaj.org/article/bc3d8052f4644c3ab893acbf99883100
Autor:
Tamara Ortiz-Cerda, Federico Argüelles-Arias, Laura Macías-García, Victoria Vázquez-Román, Gladys Tapia, Kangzhe Xie, María Desirée García-García, Manuel Merinero, Josefa-María García-Montes, Ana Alcudia, Paul K. Witting, Manuel De-Miguel
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionCrohn’s disease (CD) involves activation of mast cells (MC) and NF-кB in parallel with the PPAR-α/NLRP3 inflammasome/IL-1β pathway in the inflamed colon. Whether polyphenols from maqui (Aristotelia chilensis) represent a natural alte
Externí odkaz:
https://doaj.org/article/b9059c4a3be54cd3ba558db11889bd7f
Autor:
Federico Argüelles-Arias, Teresa Valdés Delgado, Belén Maldonado Pérez, Jaime González Antuña, Luisa Castro Laria
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Ustekinumab (UST) is indicated for the treatment of Crohn’s disease (CD) and Ulcerative Colitis (UC). Despite having shown clinical effectiveness in the real world, some patients may lose response over time or need a higher dose to achi
Externí odkaz:
https://doaj.org/article/615c5250d721430e819f379074c36c15
Autor:
Federico Argüelles-Arias, Fernando Bermejo, Joaquín Borrás-Blasco, Eugeni Domènech, Beatriz Sicilia, José M. Huguet, Antonio Ramirez de Arellano, William J. Valentine, Barnaby Hunt
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD) and can result in reduced quality of life and increased healthcare costs. IDA is treated with iron supplementation, commonly with intravenous iron f
Externí odkaz:
https://doaj.org/article/9dc02893f99d4ed581fece6ca07a0b62
Autor:
Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Yamile Zabana, María Dolores Martín-Arranz, Roser Muñoz, Mercè Navarro, Eva Sierra, Lucía Madero, Milagros Vela, José Lázaro Pérez-Calle, Empar Sainz, Xavier Calvet, Lara Arias, Victor Morales, Fernando Bermejo, Luis Fernández-Salazar, Manuel Van Domselaar, Luisa De Castro, Cristina Rodríguez, Carmen Muñoz-Villafranca, Rufo Lorente, Montserrat Rivero, Eva Iglesias, Belén Herreros, David Busquets, Joan Riera, María Pilar Martínez-Montiel, Marta Roldón, Oscar Roncero, Esther Hinojosa, Mónica Sierra, Jesús Barrio, Ruth De Francisco, José Huguet, Olga Merino, Daniel Carpio, Daniel Ginard, Fernando Muñoz, Marta Piqueras, Pedro Almela, Federico Argüelles-Arias, Guillermo Alcaín, Luis Bujanda, Noemí Manceñido, Alfredo J. Lucendo, Pilar Varela, Iago Rodríguez-Lago, Laura Ramos, Laura Sempere, Eva Sesé, Manuel Barreiro-de Acosta, Eugeni Domènech, Rubén Francés
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.MethodsProspective, observational, mult
Externí odkaz:
https://doaj.org/article/d35e6ff2cdf74ae5a842b5e0dd987f1c
Autor:
Enrique Pérez-Cuadrado-Robles, Rolando Pinho, Begoña Gonzalez, Susana Mão de Ferro, Cristina Chagas, Pilar Esteban Delgado, Cristina Carretero, Pedro Figueiredo, Bruno Rosa, Javier García Lledó, Óscar Nogales, Ana Ponte, Patrícia Andrade, Jose Francisco Juanmartiñena-Fernández, Mileidis San-Juan-Acosta, Sandra Lopes, César Prieto-Frías, Juan Egea-Valenzuela, Noemí Caballero, Eduardo Valdivieso-Cortazar, Hélder Cardoso, Consuelo Gálvez, Nuno Almeida, Pilar Borque Barrera, Blas José Gómez-Rodríguez, Francisco Sánchez Ceballos, Carlos Bernardes, Pedro Alonso, Federico Argüelles-Arias, Miguel Mascarenhas Saraiva, Enrique Pérez-Cuadrado-Martínez
Publikováno v:
GE: Portuguese Journal of Gastroenterology, Pp 1-12 (2020)
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel diseases. A panel of experts selected by the Spanish and Portuguese small bowel study groups reviewed the available evidence
Externí odkaz:
https://doaj.org/article/53730d6787fc4554abb8fa6ed7634570
Autor:
María Belvis Jiménez, Pedro Hergueta-Delgado, Blas Gómez Rodríguez, Belén Maldonado Pérez, Luisa Castro Laria, Manuel Rodríguez-Téllez, Maria Luisa Morales Barroso, Maria Dolores Galván Fernández, Maria Guerra Veloz, Victoria Alejandra Jiménez García, Rafael Romero-Castro, Antonio Benítez-Roladán, Cristina Castro Márquez, Reyes Aparcero López, Antonio Garrido-Serrano, Ángel Caunedo-Álvarez, Federico Argüelles-Arias
Publikováno v:
Endoscopy International Open, Vol 09, Iss 02, Pp E130-E136 (2021)
Background and study aims: Endoscopy plays an essential role in managing patients with ulcerative colitis (UC), as it allows us to visualize and assess the severity of the disease. As such assessments are not always objective, different scores have b
Externí odkaz:
https://doaj.org/article/e7fa3116bf474f088c31dca8aadfc2e0
Autor:
Ignacio Marin-Jimenez, Guillermo Bastida, Ana Forés, Esther Garcia-Planella, Federico Argüelles-Arias, Pilar Sarasa, Ignacio Tagarro, Alonso Fernández-Nistal, Carmen Montoto, Mariam Aguas, Javier Santos-Fernández, Marta Maia Bosca-Watts, Rocio Ferreiro, Olga Merino, Xavier Aldeguer, Xavier Cortés, Beatriz Sicilia, Francisco Mesonero, Manuel Barreiro-de Acosta
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
ObjectiveTo evaluate the impact of comorbidities and extraintestinal manifestations of inflammatory bowel disease on the response of patients with inflammatory bowel disease to antitumour necrosis factor alpha (anti-TNFα) therapy.DesignData from 310
Externí odkaz:
https://doaj.org/article/904e05fa633946ad91d91342f8b36197
Autor:
Maria-Fernanda Guerra-Veloz, Juan-María Vázquez-Morón, María Belvis-Jiménez, Héctor Pallarés-Manrique, Teresa Valdés-Delgado, Luisa Castro-Laria, Belén Maldonado-Pérez, Antonio Benítez-Roldán, Raúl Perea-Amarillo, Vicente Merino, Ángel Caunedo-Álvarez, Ángel Vilches-Arenas, Federico Argüelles-Arias
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 9, Pp 564-570 (2018)
ABSTRACT Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of biosimilar treatments such as CT-P13 will hopefully improve the availability of biological therapies. Data with regard to dru
Externí odkaz:
https://doaj.org/article/0e6345d5ab5d4913be382ed841c819f6